China NMPA approves Akeso's penpulimab for first-line treatment of nasopharyngeal cancer: Hong Kong Tuesday, March 18, 2025, 17:00 Hrs [IST] Akeso Inc., a biopharmaceutical compan ...

AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...

Of these, more than 4.5 lakh treatments worth over Rs 985 crore were undertaken for "targeted therapies" against cancer, with ...

A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.

The combination of sintilimab and fruquintinib received conditional approval from China’s National Medical Products Administration (NMPA) for the treatment of patients with advanced endometrial cancer ...

Hello, everyone, and welcome to MiNK Therapeutics fourth-quarter 2024 financial results call. Please note that this call is being recorded. (Operator Instructions) I'd now like to hand the call over ...

Ashleigh Ellerton, 29, was told she was 'too young' to get the disease. The doctor said that, given she didn't have a family history of the illness, it was unlikely to be anything serious.

Kiromic BioPharma has put 31 people on furlough. The cell therapy biotech has stopped paying the employees, which make up “substantially all” of its workforce, until it raises money to ease its cash ...

Health Minister J P Nadda on Tuesday said that more than 68 lakh cancer treatments worth over Rs 13,000 crore have been performed under the Ayushman Bharat health insurance scheme. Nadda maintained ...

Over 68 lakh cancer treatments under the Ayushman Bharat scheme, valued at over Rs 13,000 crore, have been performed, with 76 ...

The novel therapy is anticipated to function like PD-1/PD-L1 blockade with significant clinical efficacy results in ...

Biopharmaceutical company recognized for innovation in the development of immune-modulatory therapeutic cancer vaccines –NEW YORK, March 18, ...